Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia
Philadelphia (Ph)-like acute lymphoblastic leukemia (ALL) Desktop Vaporizers constitutes a heterogeneous subset of ALL with a uniformly unfavorable prognosis.The identification of mutations amenable to treatment with tyrosine kinase-inhibitors (TKIs) represents a promising field of investigation.We report the case of a young patient affected by rel